{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:34:36Z","timestamp":1793356476516,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jchromb.2026.125309","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:30:03Z","timestamp":1790519403000},"page":"125309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive composition analysis of doxorubicin HCl liposomes"],"prefix":"10.1016","volume":"1284","author":[{"given":"Nisitha","family":"Wijewantha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabath","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilak","family":"Mudalige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125309_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u2014the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125309_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jchromb.2026.125309_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jchromb.2026.125309_bb0020","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2165\/11207510-000000000-00000","article-title":"Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi\u2019s sarcoma","volume":"71","author":"Duggan","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2026.125309_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010010","article-title":"Quality by design approach in liposomal formulations: robust product development","volume":"28","author":"Alshaer","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.jchromb.2026.125309_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.talanta.2012.01.018","article-title":"An LC method for the analysis of phosphatidylcholine hydrolysis products and its application to the monitoring of the acyl migration process","volume":"94","author":"Kie\u0142bowicz","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2026.125309_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1166\/jcsb.2012.1020","article-title":"Preparation, characterization and applications of liposomes: state of the art","volume":"1","author":"Laouini","year":"2012","journal-title":"Journal of Colloid Science and Biotechnology"},{"key":"10.1016\/j.jchromb.2026.125309_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10717540490280769","article-title":"Stability of liposomal formulations in physiological conditions for oral drug delivery","volume":"11","author":"Taira","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jchromb.2026.125309_bb0045","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jchromb.2026.125309_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118906","article-title":"Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS)","volume":"574","author":"Ansar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2026.125309_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118576","article-title":"Quantitative analysis of cholesterol oxidation products and desmosterol in parenteral liposomal pharmaceutical formulations","volume":"569","author":"Wang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2026.125309_bb0060","series-title":"Bioanalytical Method Validation Guidance for Industry","author":"U. FDA","year":"2018"},{"key":"10.1016\/j.jchromb.2026.125309_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-019-2803-8","article-title":"Software tool for internal standard based normalization of lipids, and effect of data-processing strategies on resulting values","volume":"20","author":"Koelmel","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jchromb.2026.125309_bb0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/mas.21492","article-title":"Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry\u2014what, how and why?","volume":"36","author":"Wang","year":"2017","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jchromb.2026.125309_bb0075","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jpba.2009.10.001","article-title":"Analysis of cationic liposomes by reversed-phase HPLC with evaporative light-scattering detection","volume":"51","author":"Zhong","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125309_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trac.2014.04.017","article-title":"Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry","volume":"61","author":"Cajka","year":"2014","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125309_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1677\/JME-08-0150","article-title":"How to study lipidomes","volume":"42","author":"Sepp\u00e4nen-Laakso","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jchromb.2026.125309_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119077","article-title":"Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)","volume":"578","author":"Siriwardane","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2026.125309_bb0095","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s13361-019-02242-2","article-title":"The establishment of tandem mass spectrometric fingerprints of phytosterols and tocopherols and the development of targeted profiling strategies in vegetable oils","volume":"30","author":"Jiang","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125309_bb0100","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1021\/jf0532009","article-title":"HPLC separation and determination of 12 cholesterol oxidation products in fish: comparative study of RI, UV, and APCI-MS detectors","volume":"54","author":"Saldanha","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jchromb.2026.125309_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chroma.2004.12.053","article-title":"A new LC\/APCI-MS method for the determination of cholesterol oxidation products in food","volume":"1067","author":"Raith","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125309_bb0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.chroma.2008.08.095","article-title":"Effect of eluent on the ionization process in liquid chromatography\u2013mass spectrometry","volume":"1216","author":"Kostiainen","year":"2009","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125309_bb0115","series-title":"ICH Q2(R2) Guideline: Validation of Analytical Procedures","article-title":"International Council for Harmonisation of technical requirements for Pharmaceuticals for Human use","author":"I.C.f.H. (ICH)","year":"2023"},{"key":"10.1016\/j.jchromb.2026.125309_bb0120","series-title":"Validation of Analytical Procedures Q2 (R1)","author":"I. Guideline","year":"2022"},{"key":"10.1016\/j.jchromb.2026.125309_bb0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/157341311795542453","article-title":"Liposomes: a review of manufacturing techniques and targeting strategies","volume":"7","author":"Maherani","year":"2011","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.jchromb.2026.125309_bb0130","first-page":"711","article-title":"Liposomes: an overview of manufacturing techniques","volume":"10","author":"Mozafari","year":"2005","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jchromb.2026.125309_bb0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1389557516666161031120752","article-title":"Process variables and design of experiments in liposome and nanoliposome research","volume":"18","author":"Zoghi","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.jchromb.2026.125309_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-5-179","article-title":"Lysolipid containing liposomes for transendothelial drug delivery","volume":"5","author":"Koklic","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jchromb.2026.125309_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02584429","article-title":"Lysolipid exchange with lipid vesicle membranes","volume":"23","author":"Needham","year":"1995","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jchromb.2026.125309_bb0150","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","article-title":"Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape","volume":"23","author":"Zylberberg","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jchromb.2026.125309_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/C8SM01937A","article-title":"Cholesterol in phospholipid bilayers: positions and orientations inside membranes with different unsaturation degrees","volume":"15","author":"Ermilova","year":"2019","journal-title":"Soft Matter"},{"key":"10.1016\/j.jchromb.2026.125309_bb0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.fct.2018.01.017","article-title":"Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molcule","volume":"113","author":"Kaddah","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jchromb.2026.125309_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","article-title":"Influence of cholesterol on liposome stability and on in vitro drug release","volume":"5","author":"Briuglia","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jchromb.2026.125309_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jchromb.2026.125309_bb0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3762\/bjoc.11.45","article-title":"Electrochemical oxidation of cholesterol","volume":"11","author":"Morzycki","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.jchromb.2026.125309_bb0180","doi-asserted-by":"crossref","first-page":"R2299","DOI":"10.1111\/1750-3841.13423","article-title":"Current knowledge about oxysterols: a review","volume":"81","author":"Brzeska","year":"2016","journal-title":"J. Food Sci."},{"key":"10.1016\/j.jchromb.2026.125309_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/jfca.2000.0901","article-title":"Cholesterol oxidation: presence of 7-ketocholesterol in different food products","volume":"13","author":"Lercker","year":"2000","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.jchromb.2026.125309_bb0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.2000.80.1.361","article-title":"Oxysterols: modulators of cholesterol metabolism and other processes","volume":"80","author":"Schroepfer","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jchromb.2026.125309_bb0195","article-title":"Effects of dietary cholesterol and its oxidation products on pathological lesions and cholesterol and lipid oxidation in the rabbit liver","volume":"12","author":"Hur","year":"2015","journal-title":"Iowa State Univ. Anim. Ind. Rep."},{"key":"10.1016\/j.jchromb.2026.125309_bb0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tem.2017.03.002","article-title":"The role of oxysterols in human cancer","volume":"28","author":"Kloudova","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2026.125309_bb0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000012737","article-title":"Absorption of cholesterol oxidation products from ordinary foodstuff in humans","volume":"42","author":"Linseisen","year":"1998","journal-title":"Ann. Nutr. Metab."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:36:10Z","timestamp":1793352970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226003983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"alternative-id":["S1570023226003983"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125309","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive composition analysis of doxorubicin HCl liposomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125309"}}